Eleusis

Eleusis, founded in 2013, is the first privately-held, clinical-stage life sciences company dedicated to realizing the full therapeutic potential of psychedelics, guided by science and through the design of drug discovery, clinical development, and care delivery. The company's integrated discovery, development, and delivery capabilities enable it to address a wide range of unmet needs both within and beyond psychiatry.